Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Clorox Co (NYSE: CLX) closed the day trading at $127.30 down -1.81% from the previous closing price of $129.65. In other words, the price has decreased by -$1.81 from its previous closing price. On the day, 1.89 million shares were traded.
Ratios:
For a better understanding of CLX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 69.43 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.59. For the most recent quarter (mrq), Quick Ratio is recorded 0.44 and its Current Ratio is at 0.74. In the meantime, Its Debt-to-Equity ratio is 109.04 whereas as Long-Term Debt/Eq ratio is at 103.89.
On November 06, 2024, TD Cowen Upgraded its rating to Hold which previously was Sell and also upped its target price recommendation from $155 to $170. Jefferies Upgraded its Hold to Buy on October 01, 2024, whereas the target price for the stock was revised from $174 to $187.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 07 ’25 when Breber Pierre R bought 4,000 shares for $136.57 per share. The transaction valued at 546,285 led to the insider holds 4,000 shares of the business.
Marriner Kirsten sold 7,494 shares of CLX for $1,136,251 on Mar 10 ’25. The EVP – Chief People Officer now owns 27,038 shares after completing the transaction at $151.62 per share. On Mar 11 ’25, another insider, Marriner Kirsten, who serves as the EVP – Chief People Officer of the company, sold 733 shares for $150.00 each. As a result, the insider received 109,950 and left with 26,305 shares of the company.
Valuation Measures:
As of this moment, Clorox’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.86, and their Forward P/E ratio for the next fiscal year is 18.64. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.04. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.24 while its Price-to-Book (P/B) ratio in mrq is 581.12.
Stock Price History:
Over the past 52 weeks, CLX has reached a high of $171.37, while it has fallen to a 52-week low of $129.03. The 50-Day Moving Average of the stock is -7.57%, while the 200-Day Moving Average is calculated to be -17.22%.
Shares Statistics:
A total of 123.25M shares are outstanding, with a floating share count of 122.85M. Insiders hold about 0.32% of the company’s shares, while institutions hold 83.11% stake in the company.
Earnings Estimates
The performance of Clorox Co (CLX) in the stock market is under the watchful eye of 16.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is $1.55, with high estimates of $2.01 and low estimates of $1.34.
Analysts are recommending an EPS of between $7.21 and $6.85 for the fiscal current year, implying an average EPS of $7.06. EPS for the following year is $6.87, with 19.0 analysts recommending between $7.6 and $6.22.
Revenue Estimates
11 analysts predict $1.93B in revenue for the current quarter. It ranges from a high estimate of $1.98B to a low estimate of $1.9B. As of the current estimate, Clorox Co’s year-ago sales were $1.9BFor the next quarter, 11 analysts are estimating revenue of $1.6B. There is a high estimate of $1.69B for the next quarter, whereas the lowest estimate is $1.51B.
A total of 17 analysts have provided revenue estimates for CLX’s current fiscal year. The highest revenue estimate was $7.1B, while the lowest revenue estimate was $7.01B, resulting in an average revenue estimate of $7.05B. In the same quarter a year ago, actual revenue was $7.09BBased on 17 analysts’ estimates, the company’s revenue will be $6.98B in the next fiscal year. The high estimate is $7.2B and the low estimate is $6.71B.
